Saroglitazar 4 Mg in Metabolic Dysfunction‐Associated Steatotic Liver Disease: 24‐Week Results From Phase 4 Study

Arun Sanyal, Soham Doshi, Nitin Behl, Hemant Kumar Gupta, Vivek Bhatia, A. Kavitha, Mukesh Kalla, Chirag Shah, Rakhi Maiwall, Daksh Khurrana, Parshottam Koradia, Bhargav Darji, Kevinkumar Kansagra, Deven Parmar

Open source

DOI: 10.1111/liv.70558
Published: 2026-02-26
Container: Liver International
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/liv.70558,
  title = {Saroglitazar 4 Mg in Metabolic Dysfunction‐Associated Steatotic Liver Disease: 24‐Week Results From Phase 4 Study},
  author = {Arun Sanyal and Soham Doshi and Nitin Behl and Hemant Kumar Gupta and Vivek Bhatia and A. Kavitha and Mukesh Kalla and Chirag Shah and Rakhi Maiwall and Daksh Khurrana and Parshottam Koradia and Bhargav Darji and Kevinkumar Kansagra and Deven Parmar},
  year = {2026},
  journal = {Liver International},
  doi = {10.1111/liv.70558},
  url = {https://doi.org/10.1111/liv.70558}
}

RIS

TY  - JOUR
TI  - Saroglitazar 4 Mg in Metabolic Dysfunction‐Associated Steatotic Liver Disease: 24‐Week Results From Phase 4 Study
AU  - Arun Sanyal
AU  - Soham Doshi
AU  - Nitin Behl
AU  - Hemant Kumar Gupta
AU  - Vivek Bhatia
AU  - A. Kavitha
AU  - Mukesh Kalla
AU  - Chirag Shah
AU  - Rakhi Maiwall
AU  - Daksh Khurrana
AU  - Parshottam Koradia
AU  - Bhargav Darji
AU  - Kevinkumar Kansagra
AU  - Deven Parmar
PY  - 2026
JO  - Liver International
DO  - 10.1111/liv.70558
UR  - https://doi.org/10.1111/liv.70558
ER  -

APA

Sanyal, A., Doshi, S., Behl, N., Gupta, H. K., Bhatia, V., Kavitha, A., Kalla, M., Shah, C., Maiwall, R., Khurrana, D., Koradia, P., Darji, B., Kansagra, K., & Parmar, D. (2026). Saroglitazar 4 Mg in Metabolic Dysfunction‐Associated Steatotic Liver Disease: 24‐Week Results From Phase 4 Study. Liver International. https://doi.org/10.1111/liv.70558

Source records

crossref · retrieved 2026-09-25T00:04:26.147Z